Hormone receptors affect cancer growth by binding to specific hormones, which can either stimulate or inhibit cell proliferation. In breast cancer, for example, the presence of estrogen receptors (ER) and progesterone receptors (PR) can promote tumor growth when they bind to their respective hormones. Conversely, targeting these receptors with hormone-blocking therapies can inhibit tumor growth and improve patient outcomes.
